TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
TLRY

Tilray Inc

Healthcare · Drug Manufacturers - Specialty & Generic

2.60$ +0.8% vs. previous close Closing price · As of: Nov 2, 2026

Statements

Income Statement

Tilray Inc (TLRY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Revenue" came in at 915 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement TLRY
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
0.4 6.4 15 21 43 295 513 628 845 1,075 821 915
-0.2 1.4 2.3 -2.4 101 225 390 512 647 771 581 655
0.5 3.5 13 24 32 70 123 117 198 304 241 260
0.0 0.1 0.4 0.3 0.8 1.4 0.8 1.5 0.9 0.9 0.3 0.4
4.3 1.7 5.3 19 31 82 112 168 223 234 167 204
2.7 4.2 14 32 135 146 255 350 2,043 542 2,523 323
-2.2 -0.8 -1.0 -7.5 -37 -76 -132 -233 -1,845 -238 -2,283 -63
0.1 0.2 0.3 0.8 4.4 19 31 40 63 67 41 30
-4.2 -0.6 3.2 -7.8 -38 -79 -345 -441 -1,953 -339 -2,302 -88
-3.4 -0.7 0.1 4.9 0.0 -6.1 -9.0 -6.5 -9.7 -36 -121 17
-4.2 0.3 3.1 -7.8 -68 -75 -367 -477 -1,957 -334 -2,187 -123
-4.1 0.1 4.9 -5.6 -20 -45 -246 -246 -1,715 -99 -2,128 9.5

Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?